The effects of vanadium (V) absorbed by Coprinus comatus on bone in streptozotocin-induced diabetic rats

Biological Trace Element Research

Volumn 142, Issue 3, 2011, Pages 748-759

  Pei, Yi ^a   Fu, Qin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Bone biomechanics; Bone formation; Diabetes mellitus; Diabetic osteopathy; Micro CT; VACC

Indexed keywords

CALCIUM; GLUCOSE; HERBACEOUS AGENT; VANADIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITOMETRY; BONE MINERAL; BONE TURNOVER; CELL COUNT; CONTROLLED STUDY; COPRINUS; COPRINUS COMATUS; DIABETES MELLITUS; DRUG EFFECT; ENERGY ABSORPTION; FEMALE; GLUCOSE BLOOD LEVEL; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOSCLEROSIS; RAT; STREPTOZOCIN DIABETES; TRABECULAR BONE;

ANIMALS; BIOMECHANICS; BODY WEIGHT; BONE DENSITY; COPRINUS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; OSTEOGENESIS; RATS; RATS, WISTAR; VANADIUM; X-RAY MICROTOMOGRAPHY;

ANIMALIA; COPRINUS COMATUS; RATTUS;

EID: 80051790628     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-010-8825-8     Document Type: Article

References (45)

1. Tripathi BK, Srivastava AK (2006) Diabetes mellitus: complications and therapeutics. Med Sci Monit 12 (7):RA130-RA147 (Pubitemid 44031646)
2. Goodman WG, Hori MT (1984) Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization. Diabetes 33:825-831
3. Strotmeyer ES, Cauley JA (2007) Diabetes mellitus, bone mineral density, and fracture risk. Curr Opin Endocrinol Diabetes Obes 14(6):429-435 (Pubitemid 350059352)
4. Macey LR, Kana SM, Jingushi S, Terek RM, Borretos J, Bolander ME (1989) Defects of early fracturehealing in experimental diabetes. J Bone Jt Surg Am 71:722-733 (Pubitemid 19179662)
5. Katayama Y, Akatsu T, Yamamoto M, Kugai N, Nagata N (1996) Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. J Bone Miner Res 11:931-937 (Pubitemid 26200043)
6. Levin ME, Boisseau VC, Avioli LV (1976) Effects of diabetes mellitus on bone mass in juvenile and adult onset diabetics. N Engl J Med 294:241-245
7. McNair P, Madsbad C, Christiansen C, Faber OK, Transbol I, Binder C (1978) Osteopenia of insulin treated diabetes mellitus: its relation to age of onset, sex and duration of disease. Diabetologia 15:87-93
8. Rosenbloom AL, Lezotte DC, Weber T, Gudat J, Heller DR, Weber ML, Klein S, Kennedy BB (1977) Diminution of bone mass in childhood diabetes. Diabetes 26:1052-1055 (Pubitemid 8229937)
9. Santiago JV, McAlister WH, Ratzan SK, Bussman Y, Haymond MW, Shackelford G, Weldon VV (1977) Decreased cortical thickness and osteopenia in children with diabetes mellitus. Clin Endocrinol Metab 43:845-848 (Pubitemid 8212540)
10. Balint E, Szabo P, Marshall CF, Sprague SM (2001) Glucose-induced inhibition of in vitro bone mineralization. Bone 28:21-28 (Pubitemid 32114089)
11. Verhaeghe J, Suiker AM, Einhorn TA, Geusens P, Visser WJ, Van Herck E, Van Bree R, Magitsky S, Bouillon R (1994) Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: studies in diabetic and ovariectomized rats. J Bone Miner Res 9:1657-1667 (Pubitemid 24300118)
12. Paul RG, Bailey AJ (1996) Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. Int J Biochem Cell Biol 28:1297-1310 (Pubitemid 27037919)
13. Srivastava AK (2000) Anti-diabetic and toxic effects of vanadium compounds. Mol Cell Biochem 206:177-182 (Pubitemid 30246520)
14. Tsiani E, Fantus IG (1997) Vanadium compounds. Biological actions and potential as pharmaocological agents. Trends Endocrinol Metabol 8:51-58
15. Shechter Y (1990) Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes. Diabetes 39:1-5
16. Domingo JL (2002) Vanadium and tungsten derivatives as antidiabetic agents: a review of their toxic effects. Biol Trace Elem Res 88:97-112 (Pubitemid 35034421)
17. McNeill JH, Yuen VG, Hoveyda HR (1992) Bis(maltolato)oxovanadium(IV) is a potent insulin mimic. J Med Chem35(8): 1489-1491
18. Sakurai H, Fujii K, Watanabe H (1995) Orally active and long-term acting insulin-mimetic vanadyl complex: bis (picolinato) oxovanadium (IV). Biochem Biophys Res Commun 214:1095-1101
19. Swanston-Flatt SK, Day C, Bailey CJ, Flatt PR (1989) Evaluation of traditional plant treatments for diabetes: studies in streptozotocin diabetic mice. Acra Diaberologiu Larinu 26:51-55 (Pubitemid 19156691)
20. Kiho T, Tsujimura Y, Sakushima M, Usui S, Ukai S (1994) Polysaccharides in fungi: XXXIII. Hypoglycemic activity of an acidic polysaccharide (AC) from Tremella fuciformis. Yakugaku Zasshi 114:308-315, in Japanese (Pubitemid 24193508)
21. Kiho T, Sobue S, Ukai S (1994) Structural features and hypoglycemic activities of two polysaccharides from a hot-water extract of Agrocybe cylindracea. Carbohydr Res 251:81-87 (Pubitemid 24059917)
22. Kalac P, Niznamska M, Bevilaqua D, Staskova I (1996) Concentrations of mercury, copper, cadmium and lead in fruiting bodies of edible mushrooms in the vicinity of a mercury smelter and a copper smelter. Sci Total Environ 177:251-258
23. Kalac P, Svoboda L (2000) A review of trace element concentrations in edible mushrooms. Food Chem 69:273-281 (Pubitemid 30136378)
24. Han C, Yuan J, Wang Y (2006) Hypoglycemic activity of fermented mushroom of Coprinus comatus rich in vanadium. J Trace Elem Med Biol 20(3):191-196 (Pubitemid 44311020)
25. Verhulp E, van Rietbergen B, Huiskes R (2004) A three-dimensional digital image correlation technique for strain measurements in microstructures. J Biomech 37:1313-1320 (Pubitemid 38953240)
26. Goto A, Tsukamoto I (2003) Increase in tartrate-resistant acid phosphatase of bone at the early stage of ascorbic acid deficiency in the ascorbate-requiring Osteogenic Disorder Shionogi (ODS) rat. Calcif Tissue Int 73:180-185 (Pubitemid 37082365)
27. Lu B, Ennis D, Lai R, Bogdanovic E (2001) Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4). J Biol Chem 276:35589-35598
28. Semiz S, Orvig C, McNeill JH (2002) Effects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats. Mol Cell Biochem 231:23-35 (Pubitemid 34257219)
29. Goldfine AB, Simonson DC, Folli F (1995) In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus. Mol Cell Biochem 153:217-231 (Pubitemid 26003387)
30. Forst T, Pfutzner A, Kann P, Schehler B, Lobmann R, Schafer H, Andreas J, Bockisch A, Beyer J (1995) Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus. Diabetes Med 12:874-879
31. Buysschaert M, Cauwe F, Jamart J, Brichant C, De Coster P, Magnan A, Donckier J (1992) Proximal femur density in type 1 and 2 diabetic patients. Diabetes Metab 18:32-37
32. Hui SL, Epstein S, Johnston CC Jr (1985) A prospective study of bone mass in patients with type I diabetes. J Clin Endocrinol Metab 60:74-80 (Pubitemid 15194651)
33. Miazgowski T, Czekalski S (1998) A 2-year follow-up study on bone mineral density and markers of bone turnover in patients with long-standing insulin-dependent diabetes mellitus. Osteoporos Int 8:399-403 (Pubitemid 28486705)
34. Olmos JM, Perez-Castrillon JL, Garcia MT, Garrido JC, Amado JA, Gonzalez-Macias J (1994) Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus. Bone Miner 26:1-8
35. Poucheret P, Verma S, Grynpas MD, McNeill JH (1998) Vanadium and diabetes. Mol Cell Biochem 188:73-80 (Pubitemid 28493320)
36. Facchini DM, Yuen VG, Battell ML, McNeill JH, Grynpas MD (2006) The effects of vanadium treatment on bone in diabetic and non-diabetic rats. Bone 38:368-377 (Pubitemid 43255431)
37. Verhaeghe J, van Herck E, Visser WJ, Suiker AM, Thomasset M, Einhorn TA, Faierman E, Bouillon R (1990) Bone and mineral metabolism in BB rats with longterm diabetes. Decreased bone turnover and osteoporosis. Diabetes 39:477-482
38. Einhorn TA, Boskey AL, Gundberg CM, Vigorita VJ, Devlin VJ, Beyer MM (1988) The mineral and mechanical properties of bone in chronic experimental diabetes. J Orthop Res 6:317-323
39. Hou JC, Zernicke RF, Barnard RJ (1991) Experimental diabetes, insulin treatment, and femoral neck morphology and biomechanics in rats. Clin Orthop Relat Res 264:278-285
40. Pothuaud L, Rietbergen BV, Mosekilde L et al (2002) Combination of topological parameters and bone volume fraction better predicts the mechanical properties of trabecular bone. Bone 35:1091-1099 (Pubitemid 34765678)
41. Ulrich D, Rietbergen BV, Laib A, Rüegsegger P (1999) The ability of three-dimensional structure indices to reflect mechanical aspects of trabecular bone. Bone 25:55-60 (Pubitemid 29322061)
42. Bain S, Ramamurthy NS, Impeduglia T, Scolman S, Golub LM (1997) Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats. Bone 21:147-153 (Pubitemid 27395402)
43. Thomas DM, Hards DK, Rogers SD, Ng KW, Best JD (1996) Insulin receptor expression in bone. J Bone Miner Res 11:1312-1320 (Pubitemid 26282532)
44. Cornish J, Callon KE, Reid IR (1996) Insulin increases histomorphometric indices of bone formation in vivo. Calcif Tissue Int 59:492-495 (Pubitemid 26397171)
45. Fukui K, Fujisawa Y, OhyaNishiguchi H, Kamada H, Sakurai H (1999) In vivo coordination structural changes of a potent insulin-mimetic agent, bis(picolinato)oxovanadium(IV), studied by electron spin- echo envelope modulation spectroscopy. J Inorg Biochem 77:215-224 (Pubitemid 30047073)